share_log

More Unpleasant Surprises Could Be In Store For China Oral Industry Group Holdings Limited's (HKG:8406) Shares After Tumbling 30%

More Unpleasant Surprises Could Be In Store For China Oral Industry Group Holdings Limited's (HKG:8406) Shares After Tumbling 30%

中國口腔產業集團控股有限公司(HKG: 8406)的股價在暴跌30%後可能會出現更多不愉快的驚喜
Simply Wall St ·  2023/10/03 18:06

The China Oral Industry Group Holdings Limited (HKG:8406) share price has softened a substantial 30% over the previous 30 days, handing back much of the gains the stock has made lately. For any long-term shareholders, the last month ends a year to forget by locking in a 58% share price decline.

這個中國口腔產業集團控股有限公司(HKG:8406)股價在過去30天大幅下跌30%,回吐了該股最近的大部分漲幅。對於任何長期股東來說,最後一個月結束了一年的忘記,鎖定了58%的股價跌幅。

Even after such a large drop in price, you could still be forgiven for thinking China Oral Industry Group Holdings is a stock not worth researching with a price-to-sales ratios (or "P/S") of 1x, considering almost half the companies in Hong Kong's Leisure industry have P/S ratios below 0.4x. However, the P/S might be high for a reason and it requires further investigation to determine if it's justified.

即使在股價下跌如此之大之後,你仍然可以原諒中國口腔產業集團控股公司是一隻不值得研究的股票,市銷率(P/S)為1倍,考慮到香港休閒行業近一半的公司的本益比/S比率低於0.4倍。然而,P/S可能是有原因的,需要進一步調查才能確定是否合理。

See our latest analysis for China Oral Industry Group Holdings

參見我們對中國口腔產業集團控股的最新分析

ps-multiple-vs-industry
SEHK:8406 Price to Sales Ratio vs Industry October 3rd 2023
聯交所:8406市售比率與行業2023年10月3日

How China Oral Industry Group Holdings Has Been Performing

中國口腔產業集團控股有限公司的表現

As an illustration, revenue has deteriorated at China Oral Industry Group Holdings over the last year, which is not ideal at all. It might be that many expect the company to still outplay most other companies over the coming period, which has kept the P/S from collapsing. However, if this isn't the case, investors might get caught out paying too much for the stock.

舉個例子,中國口腔產業集團控股有限公司的收入在過去一年裡一直在惡化,這一點都不理想。許多人可能預計,在未來一段時間內,該公司的表現仍將好於大多數其他公司,這使得P/S指數沒有崩盤。然而,如果情況並非如此,投資者可能會被髮現為該股支付過高的價格。

We don't have analyst forecasts, but you can see how recent trends are setting up the company for the future by checking out our
我們沒有分析師的預測,但您可以通過查看我們的
free
免費
report on China Oral Industry Group Holdings' earnings, revenue and cash flow.
中國口腔產業集團控股收益、收入及現金流報告。

Is There Enough Revenue Growth Forecasted For China Oral Industry Group Holdings?

中國口腔產業集團控股的收入增長預測是否足夠?

In order to justify its P/S ratio, China Oral Industry Group Holdings would need to produce impressive growth in excess of the industry.

為了證明其P/S比率是合理的,中國口腔產業集團控股公司需要實現令人印象深刻的超出行業的增長。

In reviewing the last year of financials, we were disheartened to see the company's revenues fell to the tune of 44%. This means it has also seen a slide in revenue over the longer-term as revenue is down 35% in total over the last three years. So unfortunately, we have to acknowledge that the company has not done a great job of growing revenue over that time.

回顧過去一年的財務狀況,我們沮喪地看到該公司的收入下降到了44%。這意味著它的長期營收也出現了下滑,因為過去三年的總營收下降了35%。因此,不幸的是,我們不得不承認,在這段時間裡,該公司在收入增長方面做得並不出色。

Comparing that to the industry, which is predicted to deliver 4.3% growth in the next 12 months, the company's downward momentum based on recent medium-term revenue results is a sobering picture.

相比之下,該行業預計將在未來12個月實現4.3%的增長,根據最近的中期營收結果,該公司的下滑勢頭令人警醒。

With this information, we find it concerning that China Oral Industry Group Holdings is trading at a P/S higher than the industry. Apparently many investors in the company are way more bullish than recent times would indicate and aren't willing to let go of their stock at any price. There's a very good chance existing shareholders are setting themselves up for future disappointment if the P/S falls to levels more in line with the recent negative growth rates.

有了這些資訊,我們發現值得關注的是,中國口腔產業集團控股公司的本益比高於行業。顯然,該公司的許多投資者比最近的情況所顯示的要樂觀得多,不願以任何價格拋售他們的股票。如果本益比/S指數跌至與近期負增長更為一致的水準,現有股東很有可能正在為未來的失望做準備。

The Bottom Line On China Oral Industry Group Holdings' P/S

中國口腔產業集團控股P/S底線

China Oral Industry Group Holdings' P/S remain high even after its stock plunged. Generally, our preference is to limit the use of the price-to-sales ratio to establishing what the market thinks about the overall health of a company.

即使中國口腔產業集團股價暴跌,其本益比仍居高不下。一般來說,我們傾向於將市銷率的使用限制在確定市場對公司整體健康狀況的看法上。

Our examination of China Oral Industry Group Holdings revealed its shrinking revenue over the medium-term isn't resulting in a P/S as low as we expected, given the industry is set to grow. Right now we aren't comfortable with the high P/S as this revenue performance is highly unlikely to support such positive sentiment for long. If recent medium-term revenue trends continue, it will place shareholders' investments at significant risk and potential investors in danger of paying an excessive premium.

我們對中國口腔產業集團的調查顯示,考慮到該行業將會增長,該集團中期營收縮水並沒有導致本益比S像我們預期的那樣低。目前,我們對高本益比S並不滿意,因為這種收入表現不太可能長期支持這種積極的情緒。如果近期的中期營收趨勢持續下去,將使股東的投資面臨重大風險,潛在投資者面臨支付過高溢價的危險。

You should always think about risks. Case in point, we've spotted 4 warning signs for China Oral Industry Group Holdings you should be aware of, and 1 of them is a bit unpleasant.

你應該時刻考慮風險。舉個例子,我們發現中國口腔產業集團控股的4個警示信號你應該知道,其中一個是有點令人不快的。

Of course, profitable companies with a history of great earnings growth are generally safer bets. So you may wish to see this free collection of other companies that have reasonable P/E ratios and have grown earnings strongly.

當然了,利潤豐厚、盈利增長迅速的公司通常是更安全的押注那就是。所以你可能想看看這個免費其他本益比合理、盈利增長強勁的公司的集合。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有什麼反饋嗎?擔心內容嗎? 保持聯繫直接與我們聯繫.或者,也可以給編輯組發電子郵件,地址是暗示Wallst.com。
本文由Simply Wall St.撰寫,具有概括性.我們僅使用不偏不倚的方法提供基於歷史數據和分析師預測的評論,我們的文章並不打算作為財務建議.它不構成買賣任何股票的建議,也沒有考慮你的目標或你的財務狀況.我們的目標是為您帶來由基本面數據驅動的長期重點分析.請注意,我們的分析可能不會將最新的對價格敏感的公司公告或定性材料考慮在內.Simply Wall St.對上述任何一隻股票都沒有持倉.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論